🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Glycorex Transplantation AB (publ) (NGM:GTAB.B)
Sweden flag Sweden · Delayed Price · Currency is SEK
1.755
-0.015 (-0.85%)
At close: Nov 18, 2026

Glycorex Transplantation AB Company Description

Glycorex Transplantation AB (publ), a medical technology company, research, develops, manufactures, markets, and sells products in the field of organ transplantation or related areas.

It develops an antigen-specific immunoadsorption to reduce blood group antibodies and autoantibodies in the blood.

The company’s principal product is Glycosorb-ABO, which enables blood group incompatible kidney transplantation and is also used to enable heart, liver, lung, and stem cell transplantation procedures.

It serves in the United Kingdom, Australia, Scandinavia, Spain, Germany, and Austria. Glycorex Transplantation AB (publ) was incorporated in 1995 and is headquartered in Lund, Sweden.

Glycorex Transplantation AB (publ)
CountrySweden
Founded1995
IndustrySurgical and Medical Instruments and Apparatus
Employees20
CEOCarl-Magnus Schultz

Contact Details

Address:
ScheelevAegen 27
Lund, 223 63
Sweden
Phone46 4 62 86 52 30
Websiteglycorex.com

Stock Details

Ticker SymbolGTAB.B
ExchangeNordic Growth Market
Share ClassClass B Shares
Fiscal YearJanuary - December
Reporting CurrencySEK
ISIN NumberSE0000524530
SIC Code3841

Key Executives

NamePosition
Carl-Magnus SchultzChief Executive Officer